Email Alert | RSS    帮助

中国防痨杂志 ›› 2022, Vol. 44 ›› Issue (1): 45-48.doi: 10.19982/j.issn.1000-6621.20210685

• 专题笔谈 • 上一篇    下一篇

结核病的研究与创新——2021年世界卫生组织全球结核病报告解读

舒薇, 孙玙贤, 张立杰, 谢仕恒, 高静韬, 刘宇红()   

  1. 首都医科大学附属北京胸科医院/北京市结核病胸部肿瘤研究所/中国疾病预防控制中心结核病防治临床中心,北京 101149
  • 收稿日期:2021-12-01 出版日期:2022-01-10 发布日期:2021-12-29
  • 通信作者: 刘宇红 E-mail:liuyuhong0516@126.com
  • 基金资助:
    北京结核病综合防控关键技术研究(D181100000418005)

Tuberculosis research and innovation: Interpretation of the WHO Global Tuberculosis Report 2021

SHU Wei, SUN Yu-xian, ZHANG Li-jie, XIE Shi-heng, GAO Jing-tao, LIU Yu-hong()   

  1. Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute/Clinical Center on Tuberculosis, China CDC, Beijing 101149, China
  • Received:2021-12-01 Online:2022-01-10 Published:2021-12-29
  • Contact: LIU Yu-hong E-mail:liuyuhong0516@126.com
  • Supported by:
    Research project on key technologies for integrated tuberculosis prevention and control in Beijing(D181100000418005)

摘要:

结核病的科研与创新是实现世界卫生组织终止结核病策略目标的三大支柱之一。2021年10月14日,世界卫生组织发布了《2021年全球结核病报告》,对全球结核病科研创新进展进行了更新。笔者就全球报告中结核领域新药、新诊断技术及新疫苗等研究及创新要点进行综述,并结合我国相关领域的研究进展进行分析,以期为我国结核病领域同行掌握结核病研究动态、进一步开展原创科研和创新提供参考。

关键词: 结核, 研究, 总结性报告

Abstract:

Tuberculosis research and innovation is one of the three pillars to achieve the targets of End TB Strategy set by World Health Organization (WHO). On October 14, 2021, WHO released the Global tuberculosis report 2021, updating the newest progress of global tuberculosis research and innovation. This paper reviews the key achievements in the areas of research and innovation for new diagnostic, new drugs and new vaccines introduced in the global report, and discuss with consideration of China’s situation in related areas. The aim of this paper is to facilitate the better understanding to global research feature and development trend, and to provide reference for further China original scientific research and innovation.

Key words: Tuberculosis, Research, Consensus development conference

中图分类号: